Related Experiment Videos
[Prognostic factors and primary cerebral lymphoma]
1Service de Neurochirurgie, CHU, Poitiers.
Neuro-Chirurgie
|January 1, 1997
Summary
This study analyzed 248 patients with primary central nervous system lymphoma, identifying key factors for improved survival. Favorable prognostic indicators include younger age, radiation therapy, and anthracycline-based chemotherapy.
Area of Science:
- Neuro-oncology
- Clinical Medicine
- Radiation Oncology
Context:
- Analysis of therapeutic outcomes for 248 patients with primary central nervous system lymphoma (PCNSL) from the SFNC series (1980-1995).
- Investigation of clinical, biological, and radiological prognostic factors influencing patient survival.
Purpose:
- To identify independent prognostic factors for survival in primary central nervous system lymphoma.
- To evaluate the impact of various treatment modalities, including radiation therapy and chemotherapy, on patient outcomes.
Summary:
- Multivariate analysis identified age (<60 years), radiotherapy, and anthracycline-containing chemotherapy as independent favorable prognostic factors for PCNSL survival.
- Radiotherapy, particularly when combined with chemotherapy, showed a significant positive impact on survival.
- Partial surgical resection was identified as an unfavorable prognostic factor.
Impact:
- Provides crucial insights into prognostic indicators for primary central nervous system lymphoma, aiding in treatment planning and patient stratification.
- Highlights the importance of multimodal therapy, including radiotherapy and specific chemotherapeutic agents, in improving outcomes for PCNSL patients.
- Informs future research and clinical trial design for central nervous system lymphoma by identifying key predictive factors.